Shopping Cart
- Remove All
- Your shopping cart is currently empty
BIM-23190 is a somatostatin analog that acts as a selective agonist for SSTR2 and SSTR5 receptors. It displays potency with K i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 finds utility in cancer and acromegaly research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | Backorder |
Description | BIM-23190 is a somatostatin analog that acts as a selective agonist for SSTR2 and SSTR5 receptors. It displays potency with K i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 finds utility in cancer and acromegaly research. |
In vitro | BIM-23190 mildly stimulates PRL secretion [1]. |
In vivo | BIM-23190, administered at a dosage of 50 μg per mouse twice daily, demonstrated notable anti-tumor activity against C6 glioma in a study involving male athymic nude (nu/nu) mice aged 5-6 weeks. Over a 19-day period, the injections significantly reduced the growth rate of the tumors. |
Molecular Weight | 1202.46 |
Formula | C57H79N13O12S2 |
Cas No. | 182153-96-4 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.